Farms.com Home   News

Nofence offers innovative livestock management solutions with technology

Jan 30, 2025
By Farms.com

Virtual Fencing Made More Affordable for Livestock Farmers

Nofence, the first commercial virtual fencing company, is strengthening its presence in the U.S. by reducing prices and extending its warranty. The move supports farmers in adopting innovative livestock management solutions while making the technology more affordable.

Since entering the U.S. market, Nofence has seen rapid growth, with 45 pilot farms testing its GPS-based virtual fencing system and over 100 more farms joining after the 2024 commercial launch. This technology allows farmers to control grazing areas via a mobile app, eliminating the need for traditional fencing.

As part of its expansion, Nofence has lowered its collar prices to $289 for cattle and $199 for sheep and goats. The company is also aligning with USDA’s NRCS program, which offers financial support for virtual fencing adoption under new conservation standards.

Nofence has further increased its product warranty to five years, demonstrating its commitment to quality. With a 99.3% containment rate and extended battery life, farmers can rely on the technology to efficiently manage livestock while enhancing animal welfare.

By reducing costs and extending durability, Nofence is helping more farmers transition to virtual fencing. The company will showcase its system at CattleCon 2025 in San Antonio, Texas, from February 4-6 at Booth #3009.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.